Cutaneous manifestations associated with COVID-19 in children: A systematic review

Seema Shah1, Kiran Akhade2, Satyaki Ganguly3

  • 1Assistant Professor, Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.

Insights

COVID-19 skin manifestations in children are diverse, often presenting as acral lesions. Further investigation is crucial, as etiology remains unclear in many cases.

Area of Science:

  • Pediatric Dermatology
  • Infectious Diseases
  • Epidemiology

Background:

  • Systematic reviews on pediatric COVID-19 skin conditions are lacking.
  • Clinicians need guidance on recognizing dermatological signs during pandemics.

Purpose of the Study:

  • To systematically review and summarize cutaneous manifestations of COVID-19 in children.
  • To provide clinicians with insights into skin presentations during viral pandemics.

Main Methods:

  • Literature search of the PubMed database using keywords: COVID-19, children, and skin.
  • Inclusion criteria: English articles, pediatric cases (1 month to 18 years).
  • Analysis of 13 studies involving 149 children.

Main Results:

  • Acrally located erythematous maculopapular lesions were most common (138 children).
  • Other presentations included erythema multiforme, varicella-like exanthems, and Kawasaki disease-like symptoms.
  • Skin biopsies showed perivascular lymphocytic infiltrates; RT-PCR positive in 13.8% of cases.

Conclusions:

  • Chilblain-like lesions were observed in 43% without a confirmed cause.
  • The diverse and sometimes atypical presentations warrant consideration of COVID-19.
  • Further research is needed to establish definitive etiology and management strategies.

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
71
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
58
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49